9 results
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... Insulin Lifestyle ... #comparison #management ... endocrinology #dm2
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Management 1 ... INSULIN SENSITIZER ... ) 3 CARB ABSORPTION ... #Management #pharmacology ... #DM2 #DMII #Classification
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
α-glucosidase inhibitor ... requirements are ... #Mellitus #DM2 ... #Medications #pharmacology ... #comparison #table
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
-> Stimulates Insulin ... will stimulate insulin ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Management of Diabetes ... of an ACEi or ARB ... ml/min per 1.73 m2 ... evidence-based pharmacologic ... #KDIGO #eGFR #Insulin
Pheochromocytoma - Diagnosis and Management Summary
10 percent rule = 10% of pheochromocytomas are extra-adrenal, multiple, bilateral,
sedimentation rate, insulin ... leukocytosis, psychiatric ... monoamine oxidase inhibitors ... carbohydrate metabolism (insulin ... apparent type 2 diabetes
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
Medications: K+, ACEi/ARBs ... infusion, Calcineurin inhibitors ... transfusions), ↓insulin ... (DM, DKA, octreotide ... Elimination (see Table
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Insulin dependent ... DM ACS NSQIP: ... ACEi/ARBs - Hold ... Diabetes regimen ... medical and surgical management
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
Management of Anthracyclines ... system (RAAS) inhibitor ... hypertension, diabetes ... limited HER2 Inhibitors ... cardiology #oncology #pharmacology